OncoLink and The Group Room
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 24, 2002
Live Webcast from ASCO 2002
John P. Glees, MD, Cancer Consultant, Royal Marsden Hospital and St. George's Medical School, UK
Mario Dicato, MD, Professor of Medicine at the Luxembourg Medical Center; Head of the Research Laboratory for Cancer and Blood Disorders, Luxembourg
Hosted by Selma R. Schimmel, Host of The Group Room
James Metz, MD, Assistant Professor of Radiation Oncology, University of Pennsylvania Medical School; Editor-in-Chief of OncoLink
Gregory Curt, MD, Clinical Director, National Cancer Institute
Robert Comis, MD, Group Chair, Eastern Cooperative Oncology Group (ECOG); President, Board of Directors, the Coalition of National Cancer Cooperative Groups, Inc.; Professor of Medicine and Director, MCP Hahnemann University Clinical Trials Research Center, Philadelphia
|In order to view this live WebCast, you must have Windows Media Player. If you need a copy, click on the icon to download:|
Webcast Sponsored by Bristol-Myers Squibb Co, Ortho Biotech Products, L.P. and Pharmacia Oncology.
Jun 4, 2013 - For women with breast cancer, low-dose weekly paclitaxel is as effective as the standard-dose regimen given every two weeks, with fewer side effects; and axillary radiotherapy may be better than axillary lymph node dissection in the case of positive sentinel lymph node biopsy, according to two studies presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.